|
|
|
Insider
Information: |
Mcguire Terrance |
Relationship: |
Director |
City: |
Waltham |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
9 |
|
Direct
Shares |
184,658 |
|
Indirect Shares
|
13,007,657 |
|
|
Direct
Value |
$937,028 |
|
|
Indirect Value
|
$55,761,808 |
|
|
Total
Shares |
13,192,315 |
|
|
Total
Value |
$56,698,836 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
2
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
2
|
2
|
|
|
|
Gain/Loss Ratio : |
-2.0
|
-2.0
|
Percentage
Gain/Loss : |
-78.3%
|
-50.4%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Decode Genetics Inc |
DCGN |
Director |
2008-12-01 |
15,842 |
2008-12-01 |
101,674 |
Premium* |
|
Acusphere Inc |
ACUSD |
Director |
|
0 |
2004-05-11 |
1,099,946 |
Premium* |
|
Ironwood Pharmaceuticals Inc |
IRWD |
Director |
2019-04-01 |
73,630 |
2019-04-01 |
70,743 |
Premium* |
|
Acceleron Pharma Inc |
XLRN |
Director |
2017-03-02 |
1,250 |
2016-12-21 |
0 |
Premium* |
|
X4 Pharmaceuticals Inc |
XFOR |
Director, 10% Owner |
2017-11-20 |
0 |
2017-11-20 |
18,031 |
Premium* |
|
Alector, Inc. |
ALEC |
Director, 10% Owner |
2023-09-11 |
54,996 |
2023-09-11 |
10,893,216 |
Premium* |
|
Cyclerion Therapeutics, Inc. |
CYCN |
|
2023-11-30 |
5,552 |
2023-11-30 |
36,458 |
Premium* |
|
Seer, Inc. |
SEER |
Director |
2023-06-14 |
33,388 |
2023-06-14 |
289,929 |
Premium* |
|
Adagio Therapeutics, Inc. |
ADGI |
Director |
2021-08-10 |
0 |
2021-08-10 |
497,660 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
109 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
XLRN |
Acceleron Pharma Inc |
Director |
|
2013-09-18 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
12,070 |
|
- |
|
XLRN |
Acceleron Pharma Inc |
Director |
|
2013-09-24 |
4 |
A |
$0.00 |
$0 |
I/I |
277,520 |
3,037,693 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
Director |
|
2013-09-24 |
4 |
A |
$0.00 |
$0 |
I/I |
2,843,644 |
3,133,234 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
Director |
|
2014-05-05 |
4 |
S |
$42.86 |
$13,436,224 |
I/I |
(313,491) |
2,819,743 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
Director |
|
2014-12-11 |
4/A |
D |
$0.00 |
$0 |
I/I |
(407,256) |
2,214,482 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
Director |
|
2014-12-11 |
4 |
D |
$0.00 |
$0 |
I/I |
(403,166) |
2,218,572 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
Director |
|
2015-05-13 |
4/A |
D |
$0.00 |
$0 |
I/I |
(503,991) |
1,710,491 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
Director |
|
2015-05-13 |
4 |
D |
$0.00 |
$0 |
I/I |
(503,991) |
2,117,747 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
Director |
|
2015-05-20 |
4 |
D |
$0.00 |
$0 |
I/I |
(5,079) |
1,705,412 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
Director |
|
2015-08-17 |
4/A |
S |
$30.25 |
$12,319,585 |
I/I |
(407,259) |
1,298,153 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
Director |
|
2015-08-17 |
4 |
S |
$30.25 |
$12,319,585 |
I/I |
(407,259) |
1,303,232 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
Director |
|
2016-11-17 |
4 |
D |
$0.00 |
$0 |
I/I |
(693,020) |
605,133 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
Director |
|
2016-11-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,624 |
1,624 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
Director |
|
2016-11-18 |
4 |
D |
$0.00 |
$0 |
I/I |
(6,980) |
598,153 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
Director |
|
2016-12-07 |
4 |
OE |
$5.88 |
$1,081,344 |
I/I |
183,902 |
747,770 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
Director |
|
2016-12-08 |
4 |
S |
$30.96 |
$1,081,371 |
I/I |
(34,928) |
747,127 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
Director |
|
2016-12-21 |
4 |
A |
$0.00 |
$0 |
D/D |
2,190 |
3,814 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
Director |
|
2016-12-21 |
4 |
D |
$0.00 |
$0 |
I/I |
(747,127) |
0 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
Director |
|
2017-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,250 |
1,250 |
0 |
- |
|
ACUSD |
Acusphere Inc |
Director |
|
2003-10-07 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
133,753 |
|
- |
|
ACUSD |
Acusphere Inc |
Director |
|
2003-10-14 |
4 |
A |
$0.00 |
$0 |
I/I |
1,387,572 |
1,521,325 |
|
- |
|
ACUSD |
Acusphere Inc |
Director |
|
2004-05-11 |
4 |
D |
$6.67 |
$2,810,598 |
I/I |
(421,379) |
1,099,946 |
|
- |
|
ADGI |
Adagio Therapeutics, Inc. |
Director |
|
2021-08-10 |
4 |
B |
$17.00 |
$8,500,000 |
I/I |
500,000 |
497,660 |
2.1 |
% |
|
ADGI |
Adagio Therapeutics, Inc. |
Director |
|
2021-08-10 |
4 |
A |
$0.00 |
$0 |
I/I |
8,031,700 |
320,160 |
0 |
- |
|
ALEC |
Alector, Inc. |
Director |
|
2019-02-11 |
4 |
A |
$0.00 |
$0 |
I/I |
12,858,194 |
12,858,194 |
0 |
- |
|
109 Records found
|
|
Page 1 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|